-
公开(公告)号:HK1173151A1
公开(公告)日:2013-07-05
申请号:HK13100461
申请日:2013-01-11
Applicant: VERTEX PHARMA
Inventor: ZHANG BEILI , KRAWIEC MARIUSZ M , LUISI BRIAN B , MEDEK ALES A
IPC: C07D20060101 , A61K20060101 , A61P20060101
-
公开(公告)号:HK1158650A1
公开(公告)日:2012-09-07
申请号:HK11113172
申请日:2011-12-06
Applicant: VERTEX PHARMA
Inventor: ZHANG BEILI B , KRAWIEC MARIUSZ M , BOTFIELD MARTYN M , GROOTENHUIS PETER D J PDJ , GOOR FREDRICK F VAN
IPC: C07D20060101 , A61K20060101 , A61P20060101
-
公开(公告)号:HK1146819A1
公开(公告)日:2011-07-15
申请号:HK11100358
申请日:2011-01-14
Applicant: VERTEX PHARMA
Inventor: KESHAVARZSHOKRI ALI A , ZHANG BEILI B , KRAWIEC MARIUSZ M
IPC: C07D20060101 , A61K20060101 , A61P20060101
Abstract: The present invention relates to a substantially crystalline and free solid state form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Form I), pharmaceutical compositions thereof, and methods of treatment therewith.
-
-